Diversity of neuronal inhibition: a path to novel treatments for neuropsychiatric disorders

JAMA Psychiatry. 2014 Jan;71(1):91-3. doi: 10.1001/jamapsychiatry.2013.3059.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Anxiety / physiopathology
  • Autistic Disorder / drug therapy
  • Autistic Disorder / physiopathology
  • Depression / drug therapy
  • Depression / physiopathology
  • GABA-A Receptor Antagonists / therapeutic use
  • Humans
  • Mental Disorders / drug therapy*
  • Mental Disorders / physiopathology
  • Receptors, GABA-A / drug effects*
  • Receptors, GABA-A / physiology
  • Schizophrenia / drug therapy
  • Schizophrenia / physiopathology
  • Substance-Related Disorders / drug therapy
  • Substance-Related Disorders / physiopathology

Substances

  • GABA-A Receptor Antagonists
  • Receptors, GABA-A